An integrated approach to the diagnosis and evaluation of uterine myoma in growth rates

The incidence of uterine myoma, including rapid-growing, in a population is sufficiently high and does not tend to decrease. Therefore, assessment of growth of uterine myoma is important for the early selection of adequate tactics of these patients. At the same time, there are no clear criteria for the practitioner to decide on the optimal amount of treatment. One approach to solving this problem is the development of new methods of diagnosis of clinical and morphological variants of uterine myoma. In this regard, we studied and compared features of the structures of solids menstrual content of markers of proliferation and apoptosis (APRIL and TRAIL) in patients with slow- (simple) and rapid-growing uterine myoma. The relationship between the clinical and morphological parameters, the rate of growth of uterine myoma, the levels of APRIL and TRAIL, and abnormal structures identified in menstrual secretions of patients using the method of boundary dehydration. The study included 111 women aged 31 to 56 years. They were divided into three groups: control, which included 41 patients without gynecological diseases; the second one, which included 40 patients with slow-growing and the third one – 30 patients with rapid-growing uterine myoma. Objective: to develop a combined approach to the diagnosis of rapid-growing uterine myoma by determining structural features of the biological fluid – menstrual flow, identifying them ligand induces proliferation (APRIL), and the ligand induces apoptosis (TRAIL). The study used сlinical, biochemical, statistical methods and the method boundary dehydration of biological fluids.

1. Дикарёва Л.В., Шварёв Е.Г., Аюпова А.К. Клинико-прогностическое значение быстрорастущей миомы матки. Успехи современного естествознания 2008;(8):102–5. [Dikaryova L.V., Shvaryov Е.G., Аyupovа А.K. Clinical and prognostic value of the fast growing hysteromyoma. Uspekhi sovremennogo estestvoznaniya = Successes of Modern Natural Science 2008;(8):102–5. (In Russ.)].

2. Сидорова И.С. Миома матки. М., 2003. 255 с. [Sidorova I.S. Hysteromyoma. Мoscow, 2003. 255 p. (In Russ.)].

3. Дикарёва Л.В. Гиперпластические процессы матки: клинико-диагностическое значение маркеров биологических жидкостей. Автореф. дис. … д-ра мед. наук. Волгоград, 2009. 46 с. [Dikaryova L.V. Hyperplastic processes of the uterus: clinical and diagnostic value of biologic liquids’ markers. Author’s abstract of thesis ... of doctor of medical sciences. Volgograd, 2009. 46 p. (In Russ.)].

4. Шатохина С.Н., Шабалин В.Н. Диагностика различных патологических состояний по морфологической картине биологических жидкостей (литос-система): новая медицинская технология. М.: Хризостом,2009. 80 с. [Shatokhina S.N., Shabalin V.N. Diagnostics of different pathologic conditions by the morphologic picture of biologic liquids (lithos-system): new medical technology. Мoscow: Hrizostom, 2009. 80 p. (In Russ.)].

5. Дикарёва Л.В., Аюпова А.К., Шварёв Е.Г. и др. Диагностические аспекты акушерской и гинекологической патологии по морфологии твердой фазы биологических жидкостей (обзор). Естественные науки 2014;(3):40–8. [Dikaryova L.V., Ayupova А.K., Shvaryov Е.G. et al. Diagnostic aspects of the obstetric and gynecologic pathology by morphology of the solid phase of biologic liquids (review). Estestvennye nauki = Natural Sciences 2014;(3):40–8. (In Russ.)].

6. Davis B.J., Risinger J.I., Chandramouli G.V. et al. Gene expression in uterine leiomyoma from tumors likely to be growing (from black women over 35) and tumors likely to be nongrowing (from white women over 35). PLoS One 2013;8(6):e63909.

7. Киселёв В.И., Сидорова И.С., Унанян А.Л. Гиперпластические процессы органов женской репродуктивной системы: теория и практика. М., 2011. С. 26–37; 57–9. [Kiselev V.I., Sidorova I.S., Unanyan А.L. Hyperplastic processes of female reproductive system organs: theory and practice. Мoscow, 2011. Pp. 26–37; 57–9. (In Russ.)].

8. Коваль М.В., Аскольская С.И., Адамян Л.В. Возможности использования теломеразной активности в оценке темпов роста миомы матки. В кн.: Новые технологии в диагностике и лечении гинекологических больных. Под ред. Г.Т. Сухих, Л.В. Адамян. М., 2010. С. 137–9. [Коval’ М.V., Аskol’skaya S.I., Adamyan L.V. Possibilities of use of the telomerase activity in the evaluation of rates of the hysteromyoma growth. In: New technologies in the diagnostics and treatment of gynecologic patients. Ed. by G.Т. Sukhikh, L.V. Аdamyan. Мoscow, 2010. Pp. 137–9. (In Russ.)].

9. Dikareva L.V., Shvarеv E.G., Shvarеv G.E. Clinical meaning of rapid growth hysteromyoma, approaches to the diagnostics. Eur J Nat Hist 2008;4:44–8.

10. Шабалин В.Н., Шатохина С.Н. Морфология биологических жидкостей человека. М., 2001. 303 с. [Shabalin V.N., Shatokhina S.N. Моrphology of human biological liquids. Мoscow, 2001. 303 p. (In Russ.)].

11. Берлим Ю.Д. Маркеры пролиферативной активности и ангиогенеза у больных с гиперпластическими процессами эндометрия. Автореф. дис. … канд. мед. наук. Ростов-на-Дону, 2010. 25 с. [Berlim Yu.D. Proliferative activity and angiogenesis markers at patients with hyperplastic processes of the endometrium. Author’s abstract of thesis ... of candidate of medical sciences. Rostov-on-Don, 2010. 25 p. (In Russ.)].

12. Song C., Jin В. TRAIL (CD253), a new member of the TNF superfamily. J Biol Regul Homeost Agents 2005;19(1–2):73–7.

13. Дикарёва Л.В., Шварёв Е.Г., Теплый Д.Л. Способ диагностики гиперпластических процессов эндометрия у больных миомой матки. Патент № 2007101040/15; заявл. 09.01.2007; опубл. 20.06.2008. [Dikaryova L.V., Shvaryov Е.G., Teply D.L. Method of diagnostics of the hyperplastic processes in the endometrium at patients with hysteromyoma. Patent № 2007101040/15; application 09.01.2007; published 20.06.2008. (In Russ.)].

14. Дикарёва Л.В., Шварёв Е.Г., Шрамкова И.А., Шварёв Г.Е. Способ диагностики быстрорастущей миомы матки. Патент № 2007106294/14; заявл. 19.02.2007; опубл. 27.08.2008. [Dikaryova L.V., Shvaryov Е.G., Shramkova I.А., Shvaryov G.Е. Method of diagnostics of fast growing hysteromyoma. Patent № 2007106294/14; application 19.02.2007; published 27.08.2008. (In Russ.)].

15. Шатохина С.Н., Шабалин В.Н. Способ диагностики гиперплазии клеток организма. Патент № 2002118431/14; заявл. 10.07.2002; опубл. 27.08.2004. [Shatokhina S.N., Shabalin V.N. Method of diagnosis of hyperplasia of cells of the organism. Patent № 2002118431/14; application 10.07.2002; published 27.08.2004. (In Russ.)].